Renaissance Technologies’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$43M Buy
2,686,339
+76,000
+3% +$1.22M 0.06% 395
2025
Q1
$50.7M Buy
2,610,339
+979,900
+60% +$19M 0.08% 316
2024
Q4
$35.9M Buy
1,630,439
+115,939
+8% +$2.55M 0.05% 433
2024
Q3
$25.5M Buy
1,514,500
+330,800
+28% +$5.57M 0.04% 558
2024
Q2
$14.1M Buy
1,183,700
+214,600
+22% +$2.56M 0.02% 750
2024
Q1
$10.7M Sell
969,100
-82,056
-8% -$909K 0.02% 954
2023
Q4
$9.1M Buy
1,051,156
+727,756
+225% +$6.3M 0.01% 995
2023
Q3
$2.47M Buy
323,400
+126,100
+64% +$965K ﹤0.01% 1732
2023
Q2
$1.42M Buy
197,300
+120,700
+158% +$869K ﹤0.01% 2221
2023
Q1
$466K Buy
76,600
+63,300
+476% +$385K ﹤0.01% 2920
2022
Q4
$58K Buy
+13,300
New +$58K ﹤0.01% 3769